SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
Healthcare
$5.93 +1.98%
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.35
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
52W Low $8.30High $46.59
Volume 0.04M
Average 0.11M
Income Statement
Follow revenue through to earnings.
Revenue
$44.05M
FY 2025 · Annual
+35.0% YoYOperating Income
$4.95M
FY 2025 · Annual
-8.7% YoYNet Income
$11.81M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.01M | 16.74M | 20.4M | 32.63M | 44.05M |
| Cost of Revenue | 4.99M | 4.33M | 6.04M | 8.08M | 10.08M |
| Gross Profit | 8.02M | 12.41M | 14.36M | 24.55M | 33.97M |
| Gross Margin | 61.7% | 74.1% | 70.4% | 75.2% | 77.1% |
| Research & Development | 1.1M | 567K | 579K | 673K | 1.35M |
| Selling, General & Admin | 20.28M | 20.03M | 13.57M | 17.67M | 26.79M |
| Operating Expenses | 22.17M | 21.36M | 14.9M | 19.13M | 29.02M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| EBITDA | (18.9M) | 4.79M | (9.15M) | (16.56M) | 19.43M |
| EBITDA Margin | -145.3% | 28.6% | -44.9% | -50.8% | 44.1% |
| Operating Income | (14.14M) | (8.95M) | (540K) | 5.42M | 4.95M |
| Operating Margin | -108.7% | -53.5% | -2.6% | 16.6% | 11.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.1M | 14.13M | 15.62M | 13.64M | 6.25M |
| Other Income / Expenses | (13.09M) | (1.34M) | (25.26M) | (36.76M) | 6.95M |
| Income Before Tax | (27.23M) | (10.29M) | (25.8M) | (31.35M) | 11.9M |
| Pre-Tax Margin | -209.3% | -61.5% | -126.5% | -96.1% | 27.0% |
| Income Tax Expense | 28K | 2K | 4K | 27K | 86K |
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Net Margin | -209.5% | -61.5% | -126.5% | -96.1% | 26.8% |
| EPS (Basic) | (19.72) | (7.02) | (12.19) | (7.03) | 1.38 |
| EPS (Diluted) | (19.72) | (7.02) | (12.19) | (7.03) | 0.41 |
| 1.38M | 1.47M | 2.12M | 4.46M | 8.56M | |
| 1.38M | 1.47M | 2.12M | 4.46M | 9.08M |
SNWV Earnings Waterfall · TTM
NASDAQ:SNWV · Revenue to Net Income
Key Ratios
EPS$0.99
Gross Margin75.8%
Net Margin33.1%
P/E Ratio14.8
P/S Ratio22.7
Analysis
$44.3M of revenue converted into $16.1M of net income for the selected period. Gross margin is 75.8% and net margin is 33.1%, showing how much revenue survives after costs and taxes. EPS is $0.99, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | |
| 8-K | Current report | Aug 6, 2026 | |
| SC 13G/A | SC 13G/A filing | Jul 31, 2026 | |
| SC 13G/A | SC 13G/A filing | Jul 30, 2026 | |
| 8-K | Current report | Jul 13, 2026 |
How much revenue does SNWV generate?
SANUWAVE Health, Inc. (SNWV) reported $44.05M of revenue in fiscal 2025.
Is SNWV profitable?
SANUWAVE Health, Inc. (SNWV) reported $11.81M of net income, with a net margin of 26.8%.
Continue the stock analysis
Jump to another research area for this company.